Stocks
Immunome (IMNM) EBITDA margin US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| EBITDA margin, % | ? | -776.2% | -1 866% | |||||
| Changes by years, y/y, % | ||||||||
Immunome. EBITDA margin, %
Immunome. EBITDA margin, changes, pp
Immunome (IMNM) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | -189.1% | -131.7% | -130.0% | -2 467% | -12 831% | -1 866% | |
| Changes by years, y/y, % | -12 642pp | |||||||
| Changes by quarters, q/q, % | +57pp | +2pp | -2 337pp | -10 364pp | ||||
